Tailored Education on Inhaler Use for Adults With Asthma
Studies how tailored teaching on Nexthaler inhaler technique affects adults with asthma.
Plain-language title generated from the registry record
Registry title: The Importance of Tailored Education And Device Handling for Asthmatic Patients
Key facts
- Where
- Budapest, Csorna, Debrecen, Dunakeszi, Szeged, and Törökbálint, HungarySee the 6 sites
Where in Hungary
- National Korányi Institute of PulmonologyBudapest, HungaryNo longer taking part
- Department of Pulmonology and Allergology, Csornai MArgit HospitalCsorna, HungaryNo longer taking part
- Department of Pulmonology, Debrecen UniversityDebrecen, HungaryNo longer taking part
- Pulmonology Outpatient Clinic of DunakesziDunakeszi, HungaryNo longer taking part
- Department of Pulmonology, University of SzegedSzeged, HungaryNo longer taking part
- Calvinist Pulmonology CentreTörökbálint, HungaryNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Chiesi Hungary Ltd.
- Trial code
- NCT06840522
- Record updated
- 24 February 2025
- Original description
Significant advancements have been made in asthma medication over the past decades. Highly effective treatments are available for patients; however, both adherence and proper device usage remain below the desired levels, based on our experience and literature data. Despite the availability of numerous excellent drug-device combinations, personalized treatment for patients is still not adequately addressed.Read full original descriptionShow less
The Importance of Tailored Education And Device Handling for Asthmatic Patients
Significant advancements have been made in asthma medication over the past decades. Highly effective treatments are available for patients; however, both adherence and proper device usage remain below the desired levels, based on our experience and literature data. Despite the availability of numerous excellent drug-device combinations, personalized treatment for patients is still not adequately addressed.
In the present study, the aim is to improve patient compliance and educate symptomatic, partially, or uncontrolled asthma patients on the correct use of a specific inhalation device (Nexthaler). Considering the characteristics of the medication, the patient's lung function data, inhalation technique, and drug retention time can help estimate the expected lung deposition of the medication. By refining the inhalation technique under the guidance of the treating physician, it is hypothesized that the expected therapeutic effects of the medication may improve.
Inclusion: Physician-confirmed clinical diagnosis of asthma according to GINA guidelines; Uncontrolled asthma according to the physician's clinical assessment despite the use of appropriate therapy of Step 2 or 3, according to GINA guidelines; Patients who are eligible for the use of Foster Nexthaler 100/6 mcg according to the SmPC; Inhaled asthma therapy was changed independent from the study to Foster Nexthaler 100/6 mcg DPI maximum 1 week prior to OR on the day of study inclusion; Spirometry was performed as part of routine clinical practice; Patient able to use their Foster Nexthaler device properly after education on inhaler technique; Patient provided written, informed consent to study participation; Patient ≥ 18 years of age.
Exclusion: Participation in any clinical trial, 30 days prior to inclusion; Patients hospitalized due to an exacerbation of their asthma within the last 4 weeks prior to enrolment; Continuous use of oral corticosteroids (>5 mg prednisolone/day or >4 mg methylprednisolone/day); Use of continuous oxygen therapy; Patients with other significant diseases of the respiratory system or other organ systems that may significantly contribute to asthma symptoms (such as severe heart failure, symptomatic anaemia, functional respiratory disorders, malignant diseases etc.) according to the physician's clinical assessment; Patient is unable to execute a spirometry test; Use of biologics for asthma treatment; All exclusion criteria listed in Foster Nexthaler 100/6 SmPC.